文献速递骨质疏松与代谢性骨病

复杂区域疼痛综合征中的破骨细胞:被指控的罪魁完全无罪

Osteoclast in CRPS: an alleged guilty fully acquitted.
PubMed 文献 · Osteoporos Int · 2025-02-07

该综述基于近期关于早期复杂区域疼痛综合征(CRPS)骨转换标志物与调节因子的生化研究,重新审视生化、影像与组织病理学证据及双膦酸盐作用机制。结论认为无可靠数据支持破骨细胞活性增加,而成骨细胞活性似乎因Wnt信号增强而升高,双膦酸盐可能通过非抗破骨机制起效。

要点

  • 近期生化研究未显示急性CRPS中破骨细胞活性增加,成骨细胞活性似乎增强。
  • 诊断工具的实际意义需重新评估。
  • 双膦酸盐的作用机制可能不同于其抗破骨效应。

核心结论

  • 与近期生化研究结果一致,诊断性研究未得出可靠数据支持破骨细胞活性增加。
  • 成骨细胞活性似乎因Sclerostin和Dickkopf-1水平降低导致Wnt信号增强而升高。
  • 这些结果可能为既往诊断和治疗研究提供不同且替代性的解释。
  • 鉴于骨在CRPS发病机制中的新兴作用,这些观点可能有助于增进对该疾病病理生理学的认识。

研究设计与样本

  • 综述:根据CRPS特有的骨代谢紊乱,重新审视生化、影像学和组织病理学研究结果以及肠外双膦酸盐的可能作用机制。

主要发现

  • 与近期生化研究结果一致,诊断性研究未得出可靠数据支持破骨细胞活性增加。
  • 成骨细胞活性似乎因Sclerostin和Dickkopf-1水平降低导致Wnt信号增强而升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Contrary to popular belief, a recent study did not show increased osteoclastic activity in acute complex regional pain syndrome. Conversely, osteoblastic activity seems to be enhanced. The real meaning of diagnostic tools needs to be reassessed. Therefore, bisphosphonates act through mechanisms of action different from their anti-osteoclastic effect. INTRODUCTION: Bone tissue involvement is a widely acknowledged event in the course of complex regional pain syndrome (CRPS), and it is invariably depicted as "high turnover osteoporosis." This statement needs to be revised in light of a recent biochemical study on bone turnover markers and regulators in patients with early CRPS. METHODS: The real meaning of the findings arising from biochemical, radiological, and histopathological studies and the possible mechanism of action of parenteral bisphosphonates have been reviewed according to the bone metabolism derangement specific to this disease. RESULTS: Consistent with the results of the recent biochemical study, no reliable data emerge from diagnostic studies sustaining an increased osteoclastic activity. Conversely, osteoblastic activity seems to be enhanced for an increased Wnt signaling due to lower levels of Sclerostin and Dickkopf-1. These results may provide a different and alternative interpretation of previous diagnostic and therapeutic studies. CONCLUSIONS: For the emerging role of bone in CRPS pathogenesis, these remarks could be useful for improving knowledge of the pathophysiology of the disease.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Varenna M, Zucchi F, Di Taranto R, et al. Osteoclast in CRPS: an alleged guilty fully acquitted. Osteoporos Int. 2025. PMID: 39915338. doi:10.1007/s00198-025-07415-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。